Cellular reprogramming and the rise of rejuvenation biotech.

de Magalhães, J.P.; Ocampo, A.

doi:10.1016/j.tibtech.2022.01.011

Cellular reprogramming and the rise of rejuvenation biotech.

Détails

Demande d'une copie

ID Serval

serval:BIB_4C5B3C9CD219

Type

Article: article d'un périodique ou d'un magazine.

Sous-type

Editorial

Collection

Publications

Institution

UNIL/CHUV

Titre

Cellular reprogramming and the rise of rejuvenation biotech.

Périodique

Trends in biotechnology

Auteur⸱e⸱s

de Magalhães J.P., Ocampo A.

ISSN

1879-3096 (Electronic)

ISSN-L

0167-7799

Statut éditorial

Publié

Date de publication

06/2022

Peer-reviewed

Oui

Volume

Numéro

Pages

639-642

Langue

anglais

Notes

Publication types: Journal Article ; Research Support, Non-U.S. Gov't
Publication Status: ppublish

Résumé

Cells can be rejuvenated and biological clocks reset using cellular reprogramming. A growing number of companies now aim to use cellular reprogramming to develop therapies for rejuvenating human beings. Can the 'young' science of rejuvenation, currently mostly based on in vitro studies, drive a new biotech field toward clinical applications?

Mots-clé

Biotechnology, Cellular Reprogramming, Humans, Rejuvenation, Research Design, Yamanaka factors, aging, gene therapy, longevity

OAI-PMH

oai:serval.unil.ch:BIB_4C5B3C9CD219

DOI

10.1016/j.tibtech.2022.01.011

Pubmed

35190201

Web of science

000802813500002

Création de la notice

28/02/2022 10:48